QUINAZOLINONE COMPOUND CRYSTAL FORM, PREPARATION METHOD THEREFOR, AND USE THEREOF

Title:

QUINAZOLINONE COMPOUND CRYSTAL FORM, PREPARATION METHOD THEREFOR, AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2022/016420

Kind Code:

A1

Abstract:

A quinazolinone compound crystal form, a preparation method therefor, and a use thereof. The crystal form 1 of the compound of formula I has good stability and is easy to form into a drug, can inhibit PI3K kinase activity well, and also has higher subtype selectivity for PI3Kβ/γ/δ.

More Like This:

JP7384536	Quinazoline compounds and their preparation, use and pharmaceutical compositions
WO/2000/073279	4-PHENYL-PYRIMIDINE DERIVATIVES

Inventors:

TANG WEI (CN)
HUANG JITING (CN)
WANG ZHENYU (CN)
YANG WENQIAN (CN)

Application Number:

PCT/CN2020/103532

Publication Date:

January 27, 2022

Filing Date:

July 22, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

LUOXIN PHARMACEUTICAL SHANGHAI CO LTD (CN)
SHANDONG LUOXIN PHARMACY STOCK (CN)

International Classes:

C07D401/04; A61K31/517; A61P35/00

Domestic Patent References:

WO2019091476A1

2019-05-16

Foreign References:

CN102149711A

2011-08-10

Attorney, Agent or Firm:

SHANGHAI BESHINING LAW OFFICE (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: AUTHENTICATION DETECTION METHOD, APPARATUS AND SYSTEM

Next Patent: DRIVE STRUCTURE, LENS MODULE, AND ELECTRONIC DEVICE